Our story
Cambridge Clinical Laboratories started its journey in 2005. The objective for the company was to be a lab for the 21st century – a lab that would be an early adopter of new technologies for diagnostics. To offer personalised medicine and introduce new novel technologies and assays to help UK healthcare. This is still very much the aim today.
Core to the company’s stability is our people – many who have been around since the beginning.
2020 threw a huge curveball for the world in the form of the Covid-19 pandemic. We reacted quickly and supported the UK’s efforts with care home, hotspot and private testing. Moving forward we plan to return to our roots; concentrating on how we can support the NHS to recover, looking at what new technologies we can introduce to the UK market, and how we can help individuals take personal responsibility for their health.
Our values
Committed to quality, committed to you.
We deliver a personal service for personalised medicine that is high quality, value for money and executed in a fair timeframe. We want to exceed your expectations. We serve with integrity and high ethical values. Having previously held CPA and ISO 9001 Accreditation, in 2018 CCL became UKAS accredited to the ISO15189 standard for medical laboratories.
See here for the current scope of our accredited service.
Our culture
We treat our people well. Our team is experienced, dedicated, and loyal - we acknowledge that. We enable CPD and support this financially. We encourage innovation and practise a no blame culture. We work as a team and get rewarded as a team. We are making the changes to be greener as a business. We pay suppliers on time and we treat them fairly.
Our people
Pam Trickett
Global Sales Manager
Pam splits her time between supporting current customers and business development. She thrives on meeting customers and the people facing aspect to her role.
Pam is looking to introduce new tests in oncology and other therapeutic areas that will benefit the patient.
Pam is a keen runner, competing in several half marathons, and has even headed to the Arctic to compete in the midnight sun marathon in Norway.
Andrea Doig
QA Manager (BMS)
Andrea supports the clinical lab with all aspects of Quality Assurance and Compliance. She enjoys the collaborative and supportive environment at CCL. Out of work Andrea enjoys traveling, baking sourdough bread, listening to podcasts and spending time with her family.
Zoe Dawson
laboratory manager
Zoe is the longest-serving member of our team having been with the company since 2005. She is responsible for the operational and day to day running of the clinical laboratory. She is a qualified Biomedical scientist having completed her portfolio with the IBMS in 2013.
Maria Gomez
Laboratory Scientist
Maria works with Zoe in the lab and supports customers if required. She is driven by the human impact of her work and enjoys working with such a close-knit team.
In her down time, she plays in a samba band in Cambridge.
Natasha Cooke
Customer Services Administrator
Natasha supports with customer queries and manages the front of house in the office. When she isn’t with us, she teaches Pilates in Cambridge and London.
Clinical Consultants
Professor Clive Loveday
Virology and diagnostic services Consultant
Professor Clive Loveday brings over 50 years of experience to Cambridge Clinical Laboratories. He is highly esteemed for his work into HIV and AIDS. Since 2010 he has advised on all clinical aspects of our virology portfolio, diagnostic services, and day to day clinical queries.
Professor Loveday’s research into understanding HIV/AIDS, disease progression clinical markers, and applications for PCR to support HIV patient care, has changed the lives of those living with the disease. Since 2000, he has been the Clinical Director of the International Clinical Virology Centre Charitable Trust. His University awarded him a life-long doctorate for services in HIV training and clinical care, and in 2015 he was admitted by Her Majesty the Queen as an Officer in the Most Venerable Order of Hospital of St John of Jerusalem.
Professor Dean A. Fennell
Chair and Consultant in Thoracic Medical Oncology
Professor Dean A. Fennell has advised us on all clinical aspects of our oncology portfolio since 2016. He is a Professor of Thoracic Oncology and Director of the Leicester Mesothelioma Research Programme at Leicester University, which is focused on the identification and clinical translation of novel drug targets and predictive biomarkers for this asbestos induced cancer. He is past president of the International Mesothelioma Interest group, and former chair of the NCRI mesothelioma subgroup.